TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway

被引：0
|
作者：
Liqiang Shi [1 ]
Yajie Zhang [1 ]
Cong Yang [2 ]
Yaxin Wang [1 ]
Yichao Han [1 ]
Chuanyin Li [3 ]
Yun Yang [4 ]
Dong Dong [1 ]
Mingyuan Du [1 ]
Hecheng Li [1 ]
机构：
[1] Ruijin Hospital,Department of Thoracic Surgery
[2] Shanghai Jiao Tong University School of Medicine,Cancer Center, School of Medicine, Shanghai Tenth People’s Hospital
[3] Tongji University,Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affi
[4] Zhejiang University School of Medicine,Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Sciences, Hangzhou Institute for Advanced Study
[5] University of Chinese Academy of Sciences,undefined
来源：
Journal of Cancer Research and Clinical Oncology | / 151卷 / 4期
关键词：
TROAP; Esophageal squamous cell carcinoma; Malignant phenotype; PI3K/AKT;
D O I：
10.1007/s00432-025-06200-2
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway
    Huang, Xinyan
    Zhang, Songzhao
    Wang, Wenxi
    TISSUE & CELL, 2022, 76
  • [22] Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway
    Zhang, Xiaoxin
    Ding, Haoyue
    Lu, Zhanyi
    Ding, Liang
    Song, Yuxian
    Jing, Yue
    Hu, Qingang
    Dong, Yingchun
    Ni, Yanhong
    CELLULAR SIGNALLING, 2019, 63
  • [23] ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
    Cui, Yong
    Dong, Yong-Yong
    AGING-US, 2022, 14 (18): : 7505 - 7516
  • [24] KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE
    Sun, Fengyi
    Zhao, Tiantian
    CANCER BIOMARKERS, 2024, 41 (02) : 165 - 178
  • [25] Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway
    Ma, Shanshan
    Liu, Tengfei
    Xu, Ling
    Wang, Yaping
    Zhou, Jiankang
    Huang, Tuanjie
    Li, Peng
    Liu, Hongtao
    Zhang, Yanting
    Zhou, Xinkui
    Cui, Yuanbo
    Zang, Xingxing
    Wang, Yuming
    Guan, Fangxia
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 22400 - 22410
  • [26] SOX2 promotes tumor growth via activation of the PI3K/Akt/mTORC1 signaling pathway in esophageal squamous cell carcinoma
    Gen, Yasuyuki
    Yasui, Kohichiroh
    Kitaichi, Tomoko
    Tomie, Akira
    Ito, Yoshito
    CANCER RESEARCH, 2014, 74 (19)
  • [27] PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
    Wang, Mengmeng
    Gao, Mingjun
    Chen, Yong
    Wu, Jun
    Wang, Xiaolin
    Shu, Yusheng
    BMC CANCER, 2023, 23 (01)
  • [28] LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling
    Xu, Jianyu
    Ma, Jianli
    Guan, Bixi
    Li, Jian
    Wang, Yan
    Hu, Songliu
    CELL CYCLE, 2021, 20 (14) : 1374 - 1388
  • [29] The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma
    Wu, Ning
    Du, Zunguo
    Zhu, Yongjun
    Song, Yang
    Pang, Liewen
    Chen, Zhiming
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [30] PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
    Mengmeng Wang
    Mingjun Gao
    Yong Chen
    Jun Wu
    Xiaolin Wang
    Yusheng Shu
    BMC Cancer, 23 (1)
12345